Medtronic : Gets FDA OK for Percept PC Deep Brain Stimulation System

By Colin Kellaher

Medtronic PLC on Thursday said the U.S. Food and Drug Administration approved its Percept PC Deep Brain Stimulation system, which uses the company's BrainSense technology.

The Dublin-based medical-technology company said Percept is the first and only DBS neurostimulation system able to chronically capture and record brain signals while delivering therapy to patients with neurologic disorders associated with Parkinson's disease, essential tremor, dystonia, epilepsy or obsessive-compulsive disorder.

Medtronic said the system lets physicians track patient brain signals and correlate them with patient-recorded actions or experiences, such as symptoms, side-effects, or medication intake, enabling more personalized data-driven treatment.

Medtronic said the Mayo Clinic in Rochester, Minn., will be the first in the U.S. to implant the newly approved device.

Write to Colin Kellaher at [e-mail]